Spagnuolo A - Search Results

1

Cancer drug related cardiotoxicity during breast cancer treatment.

Giordano G, Spagnuolo A, Olivieri N, Corbo C, Campagna A, Spagnoletti I, Pennacchio RM, Campidoglio S, Pancione M, Palladino L, Villari B, Febbraro A. Giordano G, et al. Among authors: spagnuolo a. Expert Opin Drug Saf. 2016 Aug;15(8):1063-74. doi: 10.1080/14740338.2016.1182493. Epub 2016 Jul 6. Expert Opin Drug Saf. 2016. PMID: 27120499 Review.

2

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.

Gargiulo P, Arenare L, Gridelli C, Morabito A, Ciardiello F, Gebbia V, Maione P, Spagnuolo A, Palumbo G, Esposito G, Della Corte CM, Morgillo F, Mancuso G, Di Liello R, Gravina A, Schettino C, Di Maio M, Gallo C, Perrone F, Piccirillo MC. Gargiulo P, et al. Among authors: spagnuolo a. BMC Cancer. 2021 May 14;21(1):549. doi: 10.1186/s12885-021-08323-4. BMC Cancer. 2021. PMID: 33985435 Free PMC article.

3

Evolution in the treatment landscape of non-small cell lung cancer with ALK gene alterations: from the first- to third-generation of ALK inhibitors.

Spagnuolo A, Maione P, Gridelli C. Spagnuolo A, et al. Expert Opin Emerg Drugs. 2018 Sep;23(3):231-241. doi: 10.1080/14728214.2018.1527902. Epub 2018 Oct 15. Expert Opin Emerg Drugs. 2018. PMID: 30251885 Review.

4

Combining immunotherapies to treat non-small cell lung cancer.

Spagnuolo A, Gridelli C. Spagnuolo A, et al. Expert Rev Respir Med. 2019 Jul;13(7):621-634. doi: 10.1080/17476348.2019.1623027. Epub 2019 May 29. Expert Rev Respir Med. 2019. PMID: 31116072 Review.

5

Vascular endothelial growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small cell lung cancer.

Spagnuolo A, Palazzolo G, Sementa C, Gridelli C. Spagnuolo A, et al. Expert Opin Pharmacother. 2020 Mar;21(4):491-506. doi: 10.1080/14656566.2020.1713092. Epub 2020 Jan 20. Expert Opin Pharmacother. 2020. PMID: 31957503

6

The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer.

Spagnuolo A, Gridelli C. Spagnuolo A, et al. Cancers (Basel). 2023 Apr 15;15(8):2319. doi: 10.3390/cancers15082319. Cancers (Basel). 2023. PMID: 37190247 Free PMC article. Review.

7

Lung cancer, elderly and immune checkpoint inhibitors.

Casaluce F, Sgambato A, Maione P, Spagnuolo A, Gridelli C. Casaluce F, et al. Among authors: spagnuolo a. J Thorac Dis. 2018 May;10(Suppl 13):S1474-S1481. doi: 10.21037/jtd.2018.05.90. J Thorac Dis. 2018. PMID: 29951299 Free PMC article. Review.

8

"Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer": is there a substantial difference or not?

Spagnuolo A, Gridelli C. Spagnuolo A, et al. J Thorac Dis. 2018 Nov;10(Suppl 33):S4065-S4068. doi: 10.21037/jtd.2018.09.83. J Thorac Dis. 2018. PMID: 30631556 Free PMC article. No abstract available.

9

The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era.

Spagnuolo A, Muto M, Monaco F, Colantuoni G, Gridelli C. Spagnuolo A, et al. Transl Lung Cancer Res. 2019 Dec;8(6):1134-1151. doi: 10.21037/tlcr.2019.12.24. Transl Lung Cancer Res. 2019. PMID: 32010591 Free PMC article. Review.

10

The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target-a narrative review.

Spagnuolo A, Maione P, Gridelli C. Spagnuolo A, et al. Transl Lung Cancer Res. 2022 Jun;11(6):1199-1216. doi: 10.21037/tlcr-21-948. Transl Lung Cancer Res. 2022. PMID: 35832439 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page